Harvard Stem Cell Institute Names New Faculty Co-Director

Biology professor Lee Rubin is a leading expert on neurodegenerative diseases.

Smiling man with glasses in a laboratory, standing beside equipment.

Lee Rubin | PHOTOGRAPH BY KRIS SNIBBE/HARVARD UNIVERSITY

The Harvard Stem Cell Institute (HSCI) has tapped Lee Rubin as its next faculty co-director, the organization announced on Tuesday. Rubin is a professor of stem cell and regenerative biology at Harvard and a renowned scholar on neurodegenerative diseases, including Parkinson’s disease, ALS, and spinal muscular atrophy.

Effective this spring, Rubin will serve alongside David Scadden, the Jordan professor of medicine and professor of stem cell and regenerative biology at Harvard. He succeeds Doug Melton, the former Xander University Professor at Harvard who co-founded HSCI in 2005.

“Lee is joining at a particularly important time for the HSCI,” Scadden said in a university release. “We continue to move toward clinical application of discoveries…and increase emphasis on aging related conditions. He brings experience in both industry and academia along with an outstanding discovery program on the aging brain.”

Rubin, who joined Harvard in 2006, has had a long career in both industry and university research. He earned a bachelor’s in chemistry and psychology from Cornell University and a Ph.D. in neuroscience from Rockefeller University and completed his postdoctoral training in neuroscience at Harvard Medical School and Stanford University.

Rubin was a senior scientist at Athena Neurosciences, where his work on the cell biology of the blood-brain barrier led to the development of Tysabri, a multiple sclerosis drug. He served as a professor of anatomy and developmental biology at University College London, director of the Eisai London Laboratories, and chief scientific officer of the biotechnology firm Curis, Inc., in Cambridge, Massachusetts.

At Harvard, his research focuses on how aging and disease can change the nervous system. His lab uses stem cells to model the onset and development of illness, focusing on producing patient-specific neurons in an effort to develop new therapies and lead to functional improvements in patients. Rubin is also the faculty co-chair for the M.S./M.B.A. Biotechnology: Life Sciences dual master’s degree program between the Faculty of Arts and Sciences and Harvard Business School.

“I have been involved with HSCI from the moment it started,” Rubin said in a statement, “and am excited about the opportunity to help David continue to drive the exciting work carried out by the many HSCI investigators who combine their strong interest in research with an equally strong desire to contribute to the development of new therapeutics.”

Founded in 2005, HSCI is a network of hundreds of scientists and faculty across Harvard researching the use of stem cells to advance medicine across a range of research areas, including cancers, diabetes, blood and cardiovascular diseases, skin diseases, and more.

“I am delighted that Lee has agreed to serve alongside David as co-director of the Harvard Stem Cell Institute,” senior vice provost for research John H. Shaw said in a university statement, adding that Rubin’s body of work “exemplifies HSCI’s commitment to bridging the gap between academic research and real-world cures.”


Read more articles by Schuyler Velasco

You might also like

Harvard Academic Workers Call Off Strike

The union continues bargaining for a contract as members return to work, while graduate students, still on strike, agree to mediation.

Judge Vacates Trump Administration Limit on International Student Visas

Harvard was in a group of plaintiffs that filed suit against the rule in August.

Harvard Academic Workers Begin Strike

A second union joined graduate students on the picket line, emptying labs and classrooms.

Most popular

These Harvard Graduates Are Candidates for Sainthood

For advocacy and benevolence, three late alumni are reportedly in line for the Catholic Church’s highest honor.

New Names Proposed for Harvard Extension School Degrees

Long pushed for, the changes would be part of a broader rebranding for the Division of Continuing Education.

Six from Harvard Named Rhodes Scholars

Four Americans and two Canadians will begin studies at Oxford next fall.

Explore More From Current Issue

A smiling man in a brown plaid suit stands outdoors with greenery in the background.

The professor and former Harvard College dean is the next president of Harvard Magazine’s Board of Directors

Black and white portrait of a woman with medium-length hair, smiling softly.

The outgoing executive director and Harvard Business School graduate went from dancing The Nutcracker to growing a ballet company.

Delicate green cocoa pods and small white flowers on a tree branch, surrounded by soft greenery.

Harvard researchers investigate climate’s impact on cocoa crops, innovations in nasal vaccines, and links between pain and skull marrow.